LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,130,000 | +2073.1% | 7,317 | +1825.5% | 0.02% | +2300.0% |
Q3 2021 | $52,000 | +6.1% | 380 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $49,000 | -98.0% | 380 | -97.7% | 0.00% | -97.8% |
Q1 2021 | $2,490,000 | +6816.7% | 16,338 | +4315.7% | 0.05% | +4500.0% |
Q4 2020 | $36,000 | +176.9% | 370 | +168.1% | 0.00% | – |
Q3 2020 | $13,000 | -99.9% | 138 | -99.8% | 0.00% | -100.0% |
Q3 2018 | $20,177,000 | +37.8% | 73,513 | +4.0% | 1.24% | +33.9% |
Q2 2018 | $14,645,000 | +106.9% | 70,692 | +65.0% | 0.92% | +38.3% |
Q1 2018 | $7,077,000 | – | 42,854 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |